EBOS Group Limited (AU:EBO) has released an update.
EBOS Group Limited has announced the appointment of Andrew McLean as the new CEO of Medical Technology starting August 5, 2024, with outgoing CEO Matt Muscio transitioning to a non-executive director role by January 1, 2025. Additionally, the company is preparing for the retirement of Peter Williams from the Board at the 2024 Annual Meeting, following a tenure since 2013. These executive and board changes are part of EBOS’ strategic succession and renewal process.
For further insights into AU:EBO stock, check out TipRanks’ Stock Analysis page.
